Cancer, Advanced Terminated Phase 1 / 2 Trials for Nivolumab (DB09035)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0041606 (Cancer, Advanced)Terminated1 / 2 IdentifierTitlePurposeDrugs
NCT02828124A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver CancerTreatment
NCT02423954Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)Treatment